Steven Cohen's position in Sarepta Therapeutics is currently worth $27.2 Million. That's 0.09% of their equity portfolio (297th largest holding). The first Sarepta Therapeutics trade was made in Q2 2014. Since then Steven Cohen bought shares 26 more times and sold shares on 32 occasions. The stake costed the investor $26.5 Million, netting the investor a gain of 2.5% so far.